Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Research Article

JCR. 2020; 7(12): 732-737


STUDY OF PREVALENCE OF METABOLIC SYNDROME AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAM: AN ORIGINAL ARTICLE

Ajit Sambhaji Sathe, Virendra C. Patil.

Abstract
Introduction: The Coronary artery disease (CAD) and its major manifestation, myocardial infarction was a medical rarity prior to First World War. Its incidence was very low, with one case per year on an average, in large metropolitan hospitals. But since then CAD has been increasing in exponential proportions. Objectives were to find out the individual component of metabolic syndrome (MetS) in patients undergoing coronary angiogram and to classify coronary angiographic findings according to vessel affected and severity of coronary artery disease. Material and methods: This was prospective, observational cohort study done among patient undergoing coronary angiogram (CAG) for evaluation of Coronary artery disease (CAD). Total 1010 Patients enrolled in department of Medicine and Cardiology at Krishna Hospital and Medical Research Centre, Karad. Patients were examined for the presence of metabolic syndrome according to IDF 2005 guidelines. A detailed case history was taken with special reference to the symptoms, past history of type 2 Diabetes Mellitus, hypertension, dyslipidemia, smoking, alcohol consumption and tobacco chewing. Results: In the present study, 725 (71.78%) patients were males and 285 (28.21%) patients were females. 504 (49.90%) patients had a past history of type 2 Diabetes mellitus; 544 (53.86%) patients had past history of hypertension, 275 (27.22%) patients had habit of tobacco consumption, 946 (93.66%) patients undergoing coronary angiogram had waist to hip ratio >0.9, 34 (3.36%) 692 (68.51%) patients had triglycerides level ≥150 mg/dl, 496 (49.10%) patients undergoing coronary angiogram had MetS. There was statistically significant difference in gender in the proportion of MetS (Chi sq. = 94.58 for DF-1; ‘p’ < 0.0001, RR = 0.53). Conclusion: This indicates MetS was the important cluster of risk factor in the current study. Modifiable coronary artery risk factors are HTN, DM, dyslipidemia, obesity, smoking etc. Non-modifiable coronary artery risk factors are age, gender, family history etc.

Key words: Metabolic Syndrome (MetS), Coronary Angiogram, Coronary artery risk factors, waist to hip ratio



Similar Articles

Environmental stocks, CEO health risk and COVID-19.
Fernández-Méndez C, Pathan S
Research in international business and finance. 2022; 59(): 101509

Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, Díaz de León-Martínez L, Rodríguez-Aguilar M, Mizaikoff B, Flores-Ramírez R
Talanta. 2022; 236(): 122832

Neutrophil-to-lymphocyte ratio in sporadic amyotrophic lateral sclerosis.
Wei QQ, Hou YB, Zhang LY, Ou RW, Cao B, Chen YP, Shang HF
Neural regeneration research. 2022; 17(4): 875-880

Surface-based map plasticity of brain regions related to sensory motor and pain information processing after osteonecrosis of the femoral head.
Ma J, Hua XY, Zheng MX, Wu JJ, Huo BB, Xing XX, Feng SY, Li B, Xu JG
Neural regeneration research. 2022; 17(4): 806-811

Clinical Evaluation of the Rapid STANDARD Q COVID-19 Ag Test for the Screening of Severe Acute Respiratory Syndrome Coronavirus 2.
Kim HW, Park M, Lee JH
Annals of laboratory medicine. 2022; 42(1): 100-104


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites